Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid hormone replacement and metabolic function in type 2 diabetes and hypothyroidism
2011-000942-39Phase 4Active
- Sponsor
- Centre for Translational Molecular Medicine
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levothyroxine sodium in hypothyroidism, type 2 diabetes mellitus (T2DM) and Overweight, sponsored by Centre for Translational Molecular Medicine. Primary endpoints: Changes in insulin sensitivity, Changes in lipid accumulation and 1 more. Started Apr 2011; status: active.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidismtype 2 diabetes mellitus (T2DM)Overweight
Beyond the preview
Go deeper on 2011-000942-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000942-39.